(19)
(11) EP 3 395 812 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.11.2022 Bulletin 2022/44

(45) Mention of the grant of the patent:
28.09.2022 Bulletin 2022/39

(21) Application number: 18164225.7

(22) Date of filing: 24.02.2012
(51) International Patent Classification (IPC): 
C07D 403/04(2006.01)
A61P 29/00(2006.01)
 A61K 31/416(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/497; A61P 29/00; C07D 403/04

(54)

CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF CONDENSED AZACYCLES (CANNABINOID RECEPTOR MODULATORS)

KRISTALLINE FORMEN UND VERFAHREN ZUR HERSTELLUNG VON KONDENSIERTEN AZACYCLEN (CANNABINOID-REZEPTORMODULATOREN)

FORMES CRISTALLINES ET PROCÉDÉS DE PRÉPARATION D'AZACYCLES CONDENSÉS (MODULATEURS DE RÉCEPTEUR CANNABINOÏDE)

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 25.02.2011 US 201161446732 P
02.03.2011 US 201161448542 P

(43) Date of publication of application:
31.10.2018 Bulletin 2018/44

(60) Divisional application:
22197435.5

(62) Application number of the earlier application in accordance with Art. 76 EPC:
12709201.3 / 2678330

(73) Proprietor: Arena Pharmaceuticals, Inc.
New York, NY 10017 (US)

(72) Inventors:
  • BLACKBURN, Anthony C.
    San Diego, CA 92128 (US)
  • HAN, Sangdon
    San Diego, CA 92127 (US)
  • JONES, Robert M.
    San Diego, CA 92130 (US)
  • MONTALBAN, Antonio Garrido
    San Diego, CA 92129 (US)
  • PAL, Biman B.
    San Diego, CA 92129 (US)
  • RUETER, Jaimie Karyn
    San Diego, CA 92129 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)


(56) References cited: : 
WO-A1-2006/129178
FR-A1- 2 875 230
 WO-A1-2011/025541
US-B1- 7 741 350
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).